Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Director/PDMR Shareholding

11 Jul 2011 07:00

RNS Number : 0749K
Ovoca Gold PLC
11 July 2011
 

 

 

Ovoca Gold Plc ("Ovoca" or the "Company")

Director/PDMR Shareholding

Holding(s) in Company

 

 

 

Ovoca was notified today that Salyco Trading Company Ltd, a company controlled by Mr. Mikhail Mogutov (Executive Chairman of Ovoca), sold 2,371,355 ordinary shares of €0.125 each ('Ordinary Shares') at a price of GBP40p. per Ordinary Share on 8 July 2011. Following this transaction, Mr Mogutov's aggregate interest in the Company comprises 12,086,189 Ordinary Shares, representing approximately 13.66% of the issued share capital.

 

The Company was also notified today that Subishico Trading Company Ltd, a company controlled by Mr. Leonid Skoptsov (a Non-Executive Director of Ovoa), sold 2,228,645 Ordinary Shares at a price of GBP40p. per Ordinary Share on 8 July 2011. Following this transaction, Mr Skoptsov's aggregate interest in the Company comprises 12,113,189 Ordinary Shares, representing approximately 13.69% of the issued share capital.

 

Additionally, Ovoca received notification today that Trikeri Investments Ltd. had acquired 4,600,000 Ordinary Shares of the Company on 8 July 2011. Following this acquisition, Trikeri Investments Ltd.'s interest in the Company is 4,600,000 Ordinary Shares, or 5.20% of Ovoca's issued share capital.

 

 

 

 

Ovoca Gold Plc

Timothy McCutcheon +7 495 916 6029 tim.mccutcheon@ovocagold.com

 

Davy - NOMAD and joint broker

John Frain +353 1 679 6363

 

Fairfax I.S. PLC - joint broker

Ewan Leggat/Laura Littley +44 207 598 5368

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSRPMJTMBBMBRB
Date   Source Headline
29th Jul 20227:00 amRNSCompletion of Enrollment in Phase II Study
30th Jun 20227:00 amRNSAnnual Financial Report
7th Mar 20229:00 amRNSStatement re Russian Business Operations
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20223:30 pmRNSRussian Marketing Authorisation for Orenetide
31st Jan 20227:00 amRNSBoard Changes and Update
30th Dec 20217:00 amRNSDirectorate Change
4th Nov 20213:53 pmRNSHolding(s) in Company
4th Nov 20213:50 pmRNSDirector/PDMR Shareholding
4th Nov 20213:46 pmRNSBoard Change
14th Sep 20217:00 amRNSInterim Results
29th Jul 20215:00 pmRNSResult of AGM
24th Jun 20217:00 amRNSAnnual Report and Notice of AGM
10th Mar 20217:00 amRNSMigration of Participating Securities
16th Feb 20212:00 pmRNSResult of EGM
29th Jan 20217:00 amRNSFirst Patient Enrolled in Phase II Study - BP-101
25th Jan 20213:30 pmRNSNotice of EGM
5th Jan 20217:00 amRNSRe-Filing of Marketing Authorisation Application
17th Dec 20202:45 pmRNSResult of AGM
27th Nov 20203:08 pmRNSNotice of AGM
9th Oct 20207:00 amRNSAppointment of Chief Business Officer
2nd Oct 202011:06 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSUpdate re Russian Marketing Authorisation
28th Sep 20207:00 amRNSDeath of a Director
21st Sep 20207:00 amRNSInterim Results
14th Aug 202011:05 amRNSSecond Price Monitoring Extn
14th Aug 202011:00 amRNSPrice Monitoring Extension
26th Jun 20207:00 amRNSAnnual Report
14th Apr 20202:05 pmRNSSecond Price Monitoring Extn
14th Apr 20202:00 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSAcquisition of Remaining Minority Interest in IVIX
7th Nov 201912:45 pmRNSAttendance at Bio-Europe Conference
16th Sep 20197:00 amRNSInterim Results
12th Sep 20197:00 amRNSFiling of Marketing Authorisation Application
28th Aug 20197:00 amRNSDirectorate Change
8th Aug 20194:14 pmRNSResult of AGM
8th Aug 20199:05 amRNSSecond Price Monitoring Extn
8th Aug 20199:00 amRNSPrice Monitoring Extension
8th Aug 20197:00 amRNSAGM Statement
26th Jul 20197:00 amRNSDirectorate Change
25th Jul 20194:41 pmRNSSecond Price Monitoring Extn
25th Jul 20194:35 pmRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSAnnual Report and Notice of AGM
23rd Apr 20197:00 amRNSUS and EU Clinical Development Plans
29th Mar 20197:00 amRNSDirector/PDMR Shareholding
27th Mar 20197:00 amRNSOperational Update & Additional Investment in IVIX

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.